Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Belén García-Izquierdo"'
Autor:
Macarena Contreras Angulo, Belén García Izquierdo, Laura Armengod Grao, Nuria Palacios García
Publikováno v:
Endocrine Oncology, Vol 3, Iss 1, Pp 1-5 (2023)
Systemic thrombotic microangiopathy (TMA) is a serious condition whose early treatment is essential to reduce morbidity and mortality. TMA with only renal involvement has been associated with tyrosine kinase inhibitors, including lenvatinib, a drug u
Externí odkaz:
https://doaj.org/article/0ab9bc61f66f4dca9dc9f577b86a8e35
Autor:
Pedro Iglesias, Betina Biagetti, Marta Araujo-Castro, Victoria Alcázar, Fernando Guerrero-Pérez, Noelia Rivero, Anna Casteràs, Carlos García Gómez, Belén García Izquierdo, Víctor Viedma Torres, Eider Pascual-Corrales, Isabel Pavón, Carles Villabona, Fernando Cordido, Juan J. Díez
[Abstract] Background: In recent years, dopamine agonists (DAs) have become an attractive therapeutic option to prevent both tumor growth and post-surgical tumor remnant growth in clinically non-functioning pituitary adenoma (NFPA). Aim: To analyze o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40d967446a1fd17b7ca680578db3cc8
https://hdl.handle.net/2183/32378
https://hdl.handle.net/2183/32378
Autor:
Belén García Izquierdo, Macarena Contreras Angulo, Laura Armengod Grao, Álvaro García García, Pedro Iglesias
Publikováno v:
Endocrinología, Diabetes y Nutrición.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::118f3e895ed98069ec3bc7aa454052b7
https://doi.org/10.1016/j.endinu.2022.06.001
https://doi.org/10.1016/j.endinu.2022.06.001
Autor:
Juan Jose Diez, Lucía Jiménez-Mendiguchia, Ignacio Arribas Gómez, Pedro Iglesias, Cristina Pardo de Santayana, Francisco A. Bernabeu-Andreu, Ramona A. Silvestre, Rubén Romero López, Ana García-Cano, Belén García-Izquierdo, Alejandro Almería Lafuente
Publikováno v:
Advances in Laboratory Medicine, Vol 2, Iss 2, Pp 221-227 (2021)
Objectives Graves’ disease is secondary to the presence of anti-thyrotropin receptor antibodies (TRAb), which stimulate thyroid hormones. TRab determination is crucial for etiological diagnosis. The objectives of this study were (i) to compare two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e2e5e2c7bf84f26f4a5faa7e446f6b7
https://doi.org/10.1515/almed-2021-0015
https://doi.org/10.1515/almed-2021-0015
Autor:
Juan Jose Diez, Ramona A. Silvestre, Rubén Romero López, Cristina Pardo de Santayana, Pedro Iglesias, Belén García-Izquierdo, Ignacio Arribas Gómez, Lucía Jiménez-Mendiguchia, Francisco A. Bernabeu-Andreu, Alejandro Almería Lafuente, Ana García-Cano
Publikováno v:
Advances in Laboratory Medicine, Vol 2, Iss 2, Pp 229-235 (2020)
Resumen Objetivos La enfermedad de Graves (EG) es una enfermedad secundaria a la presencia de autoanticuerpos anti-receptor de TSH (TRAb) que estimulan la producción de hormonas tiroideas. La medida de la concentración de TRAb es crucial para su di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d459e72195ac4e31d40999a3b61becb5
https://doaj.org/article/e8171001252e4c1380fb0f080900c174
https://doaj.org/article/e8171001252e4c1380fb0f080900c174